PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 29(1): 26-35
2009
© 2009 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schilte, M. N.
Right arrow Articles by van den Born, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schilte, M. N.
Right arrow Articles by van den Born, J.

Bench

LONG-TERM INTERVENTION WITH HEPARINS IN A RAT MODEL OF PERITONEAL DIALYSIS

Margot N. Schilte1, Jesus Loureiro1,2, Eelco D. Keuning1, Piet M. ter Wee3, Johanna W.A.M. Celie1, Robert H.J. Beelen1 and Jacob van den Born1,a

Department of Molecular Cell Biology and Immunology,1 VU University Medical Center, Amsterdam, The Netherlands; Department of Molecular Biology,2 University Hospital La Princesa, Madrid, Spain; Department of Nephrology,3 VU University Medical Center, Amsterdam, The Netherlands a Now at Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.

a Now at Department of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.

Correspondence to: M.N. Schilte, Department of Molecular Cell Biology and Immunology, H269, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. m.schilte{at}vumc.nl

{diamondsuit} Background: Peritoneal dialysis (PD) is associated with functional and structural alterations of the peritoneal membrane, particularly new vessel formation and fibrosis. In addition to anticoagulant effects, heparin displays anti-inflammatory and angiostatic properties. Therefore, the effects of administration of heparins on function and morphology of the peritoneal membrane were studied in a rat PD model.

{diamondsuit} Methods: Rats received 10 mL conventional PD fluid (PDF) daily, with or without the addition of unfractionated heparin (UFH) or low molecular weight heparin (LMWH) in the PDF (1 mg/10 mL intraperitoneally) via a mini access port. Untreated rats served as controls. After 5 weeks, a 90-minute functional peritoneal transport test was performed and tissues and peritoneal leukocytes were taken.

{diamondsuit} Results: PD treatment induced loss of ultrafiltration (p < 0.01), a twofold increase in glucose absorption (p < 0.03), increased urea transport (p < 0.02), and loss of sodium sieving (p < 0.03), which were also found in the PDF + heparin groups. Increased peritoneal cell influx and hyaluronan production (p < 0.02) as well as an exchange of mast cells and eosinophils for neutrophils after PD treatment were observed in PD rats; addition of heparin did not affect those changes. Mesothelial regeneration, submesothelial blood vessel and matrix formation, and accumulation of tissue macrophages were seen in PD animals. Spindle-shaped vimentin-positive and cytokeratin-negative cells indicated either partial injury and denudation of mesothelial cells or epithelial-to-mesenchymal transition. Neither UFH nor LMWH affected any of these morphological changes.

{diamondsuit} Conclusion: Within 5 weeks, PD treatment induces a chronic inflammatory condition in the peritoneum, evidenced by high transport, leukocyte recruitment, tissue remodeling, and induction of spindle-shaped cells in the mesothelium. Addition of LMWH or UFH to the PDF did not prevent these adverse PDF-induced peritoneal changes.

KEY WORDS: Angiogenesis; epithelial-to-mesenchymal transition; fibrosis; heparin; mesothelium; morphology; peritoneal transport.

Received 7 January 2008; accepted 1 May 2008.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. Fabbrini, M. N. Schilte, M. Zareie, P. M. ter Wee, E. D. Keuning, R. H. J. Beelen, and J. van den Born
Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis
Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3669 - 3676.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
M. N. Schilte, J. W.A.M Celie, P. M. t. Wee, R. H.J. Beelen, and J. van den Born
FACTORS CONTRIBUTING TO PERITONEAL TISSUE REMODELING IN PERITONEAL DIALYSIS
Perit. Dial. Int., November 1, 2009; 29(6): 605 - 617.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
P. Margetts
HEPARIN AND THE PERITONEAL MEMBRANE
Perit. Dial. Int., January 1, 2009; 29(1): 16 - 19.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2009 by Multimed Inc.